Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crinetics Pharmaceuticals Inc
(NQ:
CRNX
)
53.15
-0.09 (-0.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crinetics Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
What's Going On With Crinetics Pharmaceuticals Stock?
September 12, 2023
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) shares are trading higher Tuesday.
Via
Benzinga
Nasdaq Rises Over 1%; Hostess Brands Shares Spike Higher
September 11, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded up 0.29% to 34,676.52 while the NASDAQ rose 1.16% to 13,920.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 11, 2023
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...
Via
Benzinga
9 Analysts Have This to Say About Crinetics Pharmaceuticals
August 31, 2023
Via
Benzinga
Analyst Expectations for Crinetics Pharmaceuticals's Future
August 09, 2023
Via
Benzinga
Where Crinetics Pharmaceuticals Stands With Analysts
June 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 11, 2023
Via
Benzinga
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday
September 11, 2023
The biotech company reported positive phase 3 trial results.
Via
The Motley Fool
Gold Edges Higher; Virco Manufacturing Shares Surge After Q2 Results
September 11, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crinetics Pharma's Investigational Candidate Shows Promise In Rare Type Of Hormonal Disorder
September 11, 2023
On Sunday, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) said its Phase 3 PATHFNDR-1 study evaluating paltusotine met the primary and secondary
Via
Benzinga
Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 71%
September 11, 2023
The company is working on a treatment for a growth hormone disorder.
Via
Investor's Business Daily
The Latest Analyst Ratings for Crinetics Pharmaceuticals
April 24, 2023
Via
Benzinga
Crinetics Pharmaceuticals's Return On Capital Employed Overview
December 26, 2022
Via
Benzinga
US Stocks Open Higher; Dow Jumps 150 Points
September 11, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.46% to 34,736.26 while the NASDAQ rose 0.94% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Nuwellis (NUWE) Stock Down Today?
September 11, 2023
Nuwellis (NUWE) stock is taking a beating on Monday despite a lack of news or increased trading activity for the medical device company.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 11, 2023
Via
Benzinga
Why Is Tenon Medical (TNON) Stock Down 30% Today?
September 11, 2023
Tenon Medical (TNON) stock is falling on Monday after the surgical implant company announced a proposed public offering for its shares.
Via
InvestorPlace
Why Is Versus Systems (VS) Stock Up 17% Today?
September 11, 2023
Versus Systems (VS) stock is rising higher on Monday as the business software company's shares experience heavy trading this morning.
Via
InvestorPlace
Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket
September 11, 2023
Gainers
Via
Benzinga
Why Is Crinetics Pharmaceuticals (CRNX) Stock Up 64% Today?
September 11, 2023
Crinetics Pharmaceuticals (CRNX) stock is on the rise Monday after the company announced positive clinical trial results.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 11, 2023
We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session
September 11, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Biotech Stock Crinetics Pharmaceuticals Positioned For Success In Chronic Endocrine Disorder Treatment, Says Analyst
August 31, 2023
Oppenheimer initiated coverage on Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) with an Outperform rating
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
August 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
April 24, 2023
Via
Benzinga
Crinetics Pharmaceuticals's Return On Capital Employed Overview
September 09, 2022
Benzinga Pro data, Crinetics Pharmaceuticals (NASDAQ:CRNX) reported Q2 sales of $439 thousand. Earnings fell to a loss of $42.38 million, resulting in a 22.38% decrease from last quarter.
Via
Benzinga
Crinetics Pharmaceuticals: Q2 Earnings Insights
August 12, 2022
Crinetics Pharmaceuticals (NASDAQ:CRNX) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
88 Biggest Movers From Yesterday
May 26, 2022
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...
Via
Benzinga
Crinetics Pharmaceuticals Announces Positive Top-line Results From CRN04894 Early-Stage Trial
May 25, 2022
Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) revealed positive topline results from a first-in-human Phase 1 clinical study of CRN04894 for the treatment of patients with Cushing's disease.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.